✦ LIBER ✦

Oral gold therapy in a patient with rheumatoid arthritis and preexisting uremia

✍ Scribed by Winfried Graninger; Gerald Seidl; Josef Kovarik; Wulf Pinggera; Josef S. Smolen

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 321 KB
Volume: 28
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780280618

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corneal chrysiasis. A clinical study in

Corneal chrysiasis. A clinical study in rheumatoid arthritis patients receiving gold therapy

✍ Dr. Akira Hashimoto; Yoshiharu Maeda; Hisaji Itō; Minoru Okazaki; Tōsuke Hara 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

Life-threatening hypertriglyceridemia du

Life-threatening hypertriglyceridemia during leflunomide therapy in a patient with rheumatoid arthritis

✍ F. Laborde; D. Loeuille; I. Chary-Valckenaere 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

A Controlled Trial of Gold Salt Therapy

A Controlled Trial of Gold Salt Therapy in Rheumatoid Arthritis

✍ DR Mainland; Miss M. I. Sutcliffe; Dr W. M. O'brien; L. A. Healey; W. M. Mikkeis 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

Infliximab and methotrexate as induction

Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis

✍ A. E. van der Bijl; Y. P. M. Goekoop-Ruiterman; J. K. de Vries-Bouwstra; S. ten 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

HLA-Bw35 and mucocutaneous toxicity in r

HLA-Bw35 and mucocutaneous toxicity in rheumatoid arthritis patients treated with gold

✍ Jan Tore Gran; Gunnar Husby 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Tuberculosis infection in patients with

Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy

✍ Frederick Wolfe; Kaleb Michaud; Janice Anderson; Kathy Urbansky 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

## Abstract ## Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000 incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per 100,000 persons. Recently, reports of TB following infliximab administration have raised questions